Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    9-Keto-Cannabinoid Methyl Ether

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Senzer's Respiratory Cannabinoid Device Notches Up Another Design Award
    Senzer's Respiratory Cannabinoid Device Notches Up Another Design Award

    22 Nov 2019

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/senzers-respiratory-cannabinoid-device-notches-up-another-design-award-300963914.html

    PR NEWSWIRE
    22 Nov 2019
    Share Share
    Canntab Enters Into Supply & Distribution Agreements With Exactus
    Canntab Enters Into Supply & Distribution Agreements With Exactus

    20 Nov 2019

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/canntab-achieves-key-milestone-canntab-enters-into-supply--distribution-agreements-with-exactus-for-the-purchase-of-hemp-derived-cbd-oil-and-the-distribution-of-canntabs-hard-pill-formulations-in-the-united-states-300962422.html

    PR NEWSWIRE
    20 Nov 2019
    Share Share
    GW Pharma in $300 million share sell-off
    GW Pharma in $300 million share sell-off

    02 Oct 2018

    // PHARMA LETTER

    https://www.thepharmaletter.com/in-brief/brief-gw-pharma-in-300-million-share-sell-off

    PHARMA LETTER
    02 Oct 2018
    Share Share
    Zynerba Pharma Top Line Results from ZYN001 THC-Prodrug Patch Ph 1 Study
    Zynerba Pharma Top Line Results from ZYN001 THC-Prodrug Patch Ph 1 Study

    06 Jul 2018

    // GLOBE NEWSWIRE

    https://globenewswire.com/news-release/2018/07/05/1533643/0/en/Zynerba-Pharmaceuticals-Announces-Top-Line-Results-from-ZYN001-THC-Prodrug-Patch-Phase-1-Study.html

    GLOBE NEWSWIRE
    06 Jul 2018
    Share Share